Table 4.
Factor | Comment | Reference(s) |
---|---|---|
Population studied | ||
Risk group | Prevalence rates vary between high-risk groups and low-risk groups | 29, 259 |
Sampling | ||
No. of samples | Occult HBV DNA may be intermittently detected in serum; serial sampling is ideal | 113 |
HBV DNA may be detected in liver but not in serum | 108, 238 | |
Testing | ||
HBsAg testing | Some commercial assays are better suited for detection of HBsAg mutants | 147 |
HBV DNA testing | Targeting multiple regions of the HBV genome improves detection; differences between amplification methods for HBV DNA testing exist | 108, 260 |
Geographical region | ||
HBV prevalence | Endemicity of HBV infection correlates with prevalence of occult HBV infection | 166 |
Coinfections | HCV/HIV coinfections are associated with higher rates of occult HBV infection | 29, 170 |